newsfilter
← Latest News
GlobeNewswire·

Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

VANCOUVER, British Columbia, April 19, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc (CSE:PSYG, OTCQB:PSYGF) ("Psyence"), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, and Filament Health Co